Updated Q3 2026 by CT Acquisitions.

M&A advisor for wellness center: 2026 sell-side and buy-side guide

Choosing an M&A advisor for wellness center and integrated healthcare businesses is the single decision that most determines whether an owner captures 4.0x EBITDA or 10.0x EBITDA at exit. Wellness is not a generic services vertical. It sits at the intersection of consumer discretionary, boutique healthcare, membership economics, franchise systems, and state medical-board regulation, and the private equity roll-up map in 2026 is now dense enough that a specialist advisor who already knows every active sponsor and their thesis is worth several turns of multiple on a $2M-$5M EBITDA business. This guide walks lower-middle-market wellness owners and acquirers through what a specialist advisor actually does, which platforms are buying, what multiples clear the market in Q3 2026, and how to run a competitive process that does not leak value in diligence.

What does a wellness center M&A advisor actually do?

A specialist M&A advisor for wellness center and integrated healthcare businesses runs a competitive process across the 20-30 named PE platforms and strategic acquirers actively deploying capital in wellness (Restore Hyper Wellness, Hand & Stone, Massage Envy, Milan Laser, SkinSpirit and peers), prepares the sell-side quality of earnings that reclassifies deferred revenue and add-backs correctly, and negotiates a transaction that clears at 6.0x-13.0x EBITDA depending on size and unit economics, per SkyBridge M&A Wellness Report 2025 benchmarks.

Most wellness owners think an M&A advisor is a broker with a rolodex. That understates the job by an order of magnitude. A specialist advisor works four workstreams in parallel over 6-9 months, and each of them typically moves the eventual sale price by more than the advisor fee.

The first workstream is readiness. Before a single acquirer sees the business, the advisor commissions a sell-side quality of earnings (QoE) from a national accounting firm that specializes in wellness (Frazier & Deeter, CohnReznick, and BDO all run wellness practices). The QoE reclassifies prepaid membership revenue and unused package sessions from current-period revenue to deferred revenue on a ratable basis, adds back genuine one-time owner expenses, and normalizes rent to market where the seller owns the building. Getting this right can add or subtract 20%-30% of reported EBITDA before a single buyer meeting.

The second workstream is positioning. The advisor drafts a confidential information memorandum (CIM), typically 40-70 pages, that segments revenue by service line (membership dues, injectables, IV therapy, body contouring, retail), presents same-store sales growth against a de novo growth story, and benchmarks the business against the platform peers using publicly available data. The CIM either lands the reader at 8x or 10x within the first 15 pages, or it doesn’t.

The third workstream is process. The advisor runs a limited or broad auction with 20-60 targeted acquirers, collects indications of interest (IOIs), narrows to 5-10 for management meetings, converts to 2-4 letters of intent (LOIs), and negotiates the winning LOI to include specific protections around deferred revenue, working capital peg, escrow, and rep-and-warranty insurance. According to GF Data, deals that go to 4-6 LOIs clear at multiples 1.0x-2.0x higher than deals with a single bid.

The fourth workstream is diligence defense. During the 60-90 day exclusive period, the advisor manages buyer QoE, legal, commercial, HR, IT, and regulatory workstreams, and pushes back on every re-trade attempt. This is where deals get killed or shrunk by 1.0x-2.0x turns of EBITDA. In wellness, the most common re-trade drivers are deferred revenue restatement, medical director agreements that do not meet state CPOM requirements, employee misclassification (aestheticians and injectors as 1099 contractors when they should be W-2), and OSHA-related lease compliance issues.

Why do wellness center owners need a specialized M&A advisor, not a generic broker?

A generic business broker averages 4-8 deals per year across restaurants, HVAC, retail, and light manufacturing. A specialist wellness advisor works only in wellness and adjacent healthcare, knows every buyer at Restore Hyper Wellness (General Atlantic), Hand & Stone (Levine Leichtman), and Milan Laser (TA Associates) by name, and understands why the deferred revenue and CPOM issues re-trade wellness deals by 1.0x-1.5x EBITDA when handled poorly, which per Axial is the top reason wellness deals break at LOI stage.

The gap between a generic broker and a wellness specialist becomes visible in three places. First is buyer coverage. A generic broker might send a teaser to 100 acquirers listed in a database. A specialist advisor knows the ten sponsors actively writing checks in wellness this quarter, whether Shore Capital’s Bespoke Wellness Partners is prioritizing recovery modalities or aesthetics right now, and which LP capital drove Levine Leichtman’s 2024 Hand & Stone recap. That coverage difference typically produces 3x-5x more competitive bids at LOI.

Second is industry vocabulary. When a buyer’s associate asks the seller how they calculate ARPM (average revenue per member), attach rate on injectables, or utilization on their IV therapy rooms, a generic broker cannot coach the answer. A specialist advisor has watched 30 sellers give the same answer and knows which phrasing lands. Small vocabulary matters in the first 20 minutes of a management meeting because it signals platform-readiness or amateur-hour.

Third is QoE nuance. Wellness has half a dozen accounting quirks that show up in every deal: deferred revenue on unused package sessions, gift card liabilities, credit card processing reserves, chargeback exposure on cosmetic procedures, and Botox or filler inventory that requires cold-chain documentation to preserve resale value at close. A generic broker will hand these to any accounting firm. A specialist will preemptively address them in the sell-side QoE and eliminate 60%-80% of buyer re-trade opportunities before they surface.

What EBITDA multiples are wellness center businesses selling for in 2026?

Wellness center EBITDA multiples in Q3 2026 range from 3.0x-4.5x for owner-operated single-location businesses under $500K EBITDA to 10.0x-13.0x for multi-unit corporate-owned platforms above $10M EBITDA, per SkyBridge M&A Wellness Report 2025 and quarterly market updates from Provident Healthcare Partners. The market is currently paying premium multiples for recurring membership revenue above 50% of top line, ancillary service attach rates above 25%, and clean unit economics across 5+ locations.

Wellness center and integrated healthcare EBITDA multiples by size band, Q3 2026

EBITDA band	Typical multiple	Typical enterprise value	Typical acquirer	Key value driver
Under $500K	3.0x-4.5x	$1.5M-$2.25M	Individual, search fund, local operator	Owner-dependent, single-location, transferability
$500K-$1M	4.5x-6.0x	$2.25M-$6M	Local roll-up, family office	Second location proven, 2+ years management team
$1M-$3M	6.0x-8.0x	$6M-$24M	Regional roll-up, lower LMM PE	3-5 locations, repeatable de novo playbook
$3M-$10M	8.0x-10.0x	$24M-$100M	PE add-on to platform (Restore, Hand & Stone)	Multi-unit, ARPM > $2K, retention > 80%
$10M-$25M	10.0x-13.0x	$100M-$325M	PE platform (General Atlantic, Roark, TA)	Platform of record, 10+ locations, CMO installed
$25M+	12.0x-15.0x	$300M+	Mega-cap PE, strategic (Equinox, Lifetime)	National platform, EBITDA growing > 20%/yr

Sources: Provident Healthcare Partners quarterly wellness updates, SkyBridge M&A Wellness Report 2025, PitchBook Q4 2025 Healthcare Services Report.

Three factors compress or expand these ranges. Recurring revenue mix is the largest single driver. A business at $2M EBITDA where 70% of revenue is contractually recurring membership dues would typically clear the top of its band (closer to 8x), while a business at the same EBITDA with 20% recurring and 80% transactional would clear near the bottom (closer to 6x). Same-store sales growth is the second driver. Buyers pay for organic growth without CapEx. A business showing 8%-15% same-store growth for three consecutive years would typically expand its multiple by 1.0x-1.5x. Unit economics discipline is the third. Businesses with documented four-wall EBITDA margins above 22%, membership cost of acquisition (CAC) under $250, and lifetime value (LTV) above $2,500 clear the top of their band, per Bain Global Healthcare PE Report 2025 unit-economics benchmarks for consumer healthcare.

Which PE platforms are actively acquiring wellness center businesses right now?

Six PE-backed platforms account for the majority of wellness center transaction volume in 2024-2026: Restore Hyper Wellness (backed by General Atlantic since the 2022 recap), Hand & Stone Massage (recapitalized by Levine Leichtman Capital Partners in 2024), Massage Envy (owned by Roark Capital since 2012), Bespoke Wellness Partners (backed by Shore Capital, Chicago), Milan Laser Hair Removal (majority-owned by TA Associates through 2025), and SkinSpirit (acquired by Leonard Green & Partners in 2021 with continuing tuck-in activity in Texas and California through 2025).

Named PE-backed platforms actively acquiring wellness center and integrated healthcare businesses, 2024-2026

Platform	Sponsor	HQ	Focus	Recent activity
Restore Hyper Wellness	General Atlantic (recap 2022)	New York, NY	Franchise wellness, cryo, IV, red light	Continued unit acquisitions through 2025 (PE Hub)
Hand & Stone Massage	Levine Leichtman Capital Partners	Los Angeles / Trevose PA	Franchise massage & facial	2024 recap, actively acquiring franchisees back (LLCP)
Massage Envy	Roark Capital (since 2012)	Atlanta, GA / Scottsdale AZ	Largest US wellness franchise	1,100+ locations, systemwide upgrades & corporate reacquisition
Bespoke Wellness Partners	Shore Capital Partners	Chicago, IL	Massage & recovery multi-brand	Building platform in 2024-2026 via Shore’s microcap thesis (Shore)
Milan Laser Hair Removal	TA Associates (majority since 2021)	Omaha, NE	Corporate-owned laser hair removal	Continued unit expansion, 380+ clinics by 2025 (TA Associates)
SkinSpirit	Leonard Green & Partners (since 2021)	Palo Alto, CA	Aesthetics, injectables, skin health	2024-2025 tuck-ins in TX and CA (Modern Aesthetics)
Ideal Image (post-restructure)	L Catterton (asset acquisition 2024)	Tampa, FL	Med-spa, aesthetics, laser	Reset platform after bankruptcy, selective acquisitions (L Catterton)
Xponential Fitness (wellness tuck-ins)	Public (NYSE: XPOF)	Irvine, CA	Boutique fitness with wellness (StretchLab, Row House)	Portfolio wellness expansion through 2025

Each platform runs a distinct thesis. Restore Hyper Wellness under General Atlantic prioritizes multi-modality wellness (cryo, IV, red light, oxygen) and continues to acquire high-volume franchisees back to corporate ownership. Hand & Stone under Levine Leichtman rebased its unit economics in the 2024 recap and is aggressively converting successful franchisees into corporate stores where lease and demographic overlap justify. Massage Envy under Roark, the largest wellness franchise in the U.S., focuses on systemwide technology upgrades and reacquiring the largest franchisee groups. Bespoke Wellness Partners under Shore Capital follows Shore’s microcap healthcare thesis, buying $500K-$3M EBITDA businesses and building regional density.

Milan Laser, under TA Associates, is unusual in being corporate-owned rather than franchised, and its unit economics discipline (single-modality, single-service, geographic clustering) has produced the highest four-wall margins in the vertical. SkinSpirit under Leonard Green & Partners has built a west-coast injectables platform and continues to acquire multi-location aesthetics practices in Texas and California. Ideal Image, restructured after 2024 bankruptcy proceedings and acquired at the asset level by L Catterton, is rebuilding as a leaner med-spa platform.

A specialist advisor knows not only these platforms but each sponsor’s current dry powder, remaining fund life, and portfolio company reporting priorities. That intelligence determines which platforms to approach first and how to shape the CIM narrative for each.

Who are the strategic acquirers in wellness M&A?

Strategic acquirers in wellness are rarer than PE, because most large wellness operators are already PE-backed. The largest strategics active in 2024-2026 are Lifetime Fitness (owned by Leonard Green & TPG, Chanhassen MN), Equinox Group (which acquired Blink Fitness and integrates wellness brands), Woodhouse Spa (LNK Partners, Purchase NY), and Beauty Health Company (public, NASDAQ: SKIN, Hydrafacial platform). Xponential Fitness Holdings (NYSE: XPOF) also acts as a strategic when its portfolio brands tuck in wellness capacity.

Understanding the difference between strategic and PE acquirers matters for a seller because the two groups underwrite differently. A strategic in wellness would typically pay for revenue synergies (cross-selling into an existing membership base) and cost synergies (consolidated back office, shared marketing spend, procurement scale on injectables and consumables). A strategic acquirer often pays 0.5x-1.5x higher multiple than a PE add-on when the synergies are real and defensible.

A PE platform, by contrast, underwrites standalone unit economics and pays a multiple that reflects platform-quality risk. The upside for the seller in PE processes is rollover equity at platform value, which if the platform exits at 12x-14x can convert a 3x rollover into 4x-5x MOIC at exit. The tradeoff is a longer lockup and integration risk.

A specialist advisor will typically run a dual-track process in wellness deals above $5M EBITDA, deliberately including both strategic and PE acquirers to force competitive tension between synergy-driven bids and platform-driven bids. Per Axial Middle Market Reports, dual-track wellness processes have cleared at multiples 1.5x-2.5x higher than single-track PE processes in 2024-2025.

What buyer archetypes are most active in wellness?

Five buyer archetypes drive wellness M&A volume in 2026: (1) PE-backed platform acquirers doing add-ons (Restore, Hand & Stone, Massage Envy), (2) Shore Capital-style microcap builders (Bespoke Wellness Partners), (3) strategic multi-brand operators (Lifetime, Equinox), (4) family offices building regional wellness portfolios, and (5) independent sponsors and search funds acquiring their first platform below $2M EBITDA. Each underwrites differently and requires different CIM positioning.

The first archetype, PE platform add-ons, is where 60%+ of wellness volume happens. These buyers know the vertical, move quickly, and pay the highest multiples if the target has clean data and geographic fit. They will typically move from IOI to LOI in 45-60 days.

The second archetype, Shore Capital-style microcap builders, targets sub-$3M EBITDA businesses and prefers to buy at 6x-7x on a proprietary basis. These buyers assemble platforms from the ground up and often become the acquirer of choice for owner-operators who value fair pricing and continuity of employment for their teams.

The third archetype, strategic multi-brand operators, is small in number but writes large checks. A strategic buyer would typically pay a premium for geographic fill-in (e.g., Equinox needing wellness capacity in a specific MSA) or product fill-in (e.g., a fitness operator adding recovery modalities). These deals are rare (2-4 per year across the vertical) but transformative.

The fourth archetype, family offices, has grown meaningfully since 2022. Wellness fits a family office thesis because it produces cash flow, has consumer-brand upside, and does not require deep operational expertise if bought alongside a competent management team. Family offices typically pay in-between multiples (6.5x-8x) and offer longer hold periods, which some sellers prefer for cultural reasons.

The fifth archetype, independent sponsors and search funds, targets sub-$2M EBITDA wellness businesses and represents about 15%-20% of transaction count but a much smaller share of dollar volume. These buyers require capital commitments from LPs on a deal-by-deal basis, which can slow processes, but they also pay reasonable multiples (5x-7x) for owner-operated businesses and offer succession-friendly deal structures.

What wellness center-specific value drivers increase the sale multiple?

Eight value drivers move wellness center multiples up: (1) recurring membership revenue above 50% of top line, (2) monthly member churn below 4%, (3) ancillary service attach rate above 25% (injectables, IV, retail on top of memberships), (4) same-store sales growth of 8%+ for three consecutive years, (5) location density in 2+ contiguous MSAs, (6) documented medical director agreements that satisfy state CPOM rules, (7) four-wall EBITDA margin above 22%, and (8) a repeatable de novo playbook proven across at least three locations under 24 months old, per Bain and Provident Healthcare benchmarks.

Value drivers that increase wellness center EBITDA multiples in 2026

Value driver	Threshold to move multiple up	Approximate multiple impact	Why buyers pay
Recurring membership revenue %	> 50% of top line	+1.0x to +2.0x	Predictable cash flow, lower CAC on incremental revenue
Monthly membership churn	< 4% monthly	+0.5x to +1.5x	Long LTV, defensible unit economics
Ancillary attach rate	> 25% of member revenue	+0.5x to +1.0x	Higher ARPM, demonstrates upsell discipline
Same-store sales growth	> 8%/yr for 3 years	+1.0x to +1.5x	Organic growth without CapEx
Geographic density (locations per MSA)	> 3 in one MSA	+0.5x to +1.0x	Marketing efficiency, brand density, back-office scale
Documented CPOM compliance	12+ months clean MSO-PC docs	+0.5x (avoids re-trade)	Removes legal risk, avoids re-trade of 1.0x-1.5x
Four-wall EBITDA margin	> 22%	+0.5x to +1.5x	Proves unit-level profitability at scale
Repeatable de novo playbook	3+ locations under 24 months old ramped	+1.0x to +2.0x	Demonstrates growth capacity for platform buyer

Stacking these drivers is where valuation compounds. A $2M EBITDA business hitting the top of every threshold above would typically clear 9.5x-10.5x in 2026, materially above the 6.0x-8.0x mid-band range shown earlier. That is the value of a specialist advisor who understands which drivers to build and which to document 6-18 months before going to market.

In our experience advising wellness center owners at CT Acquisitions, the single highest-ROI pre-sale investment is a cohort-based membership retention report, ideally cut monthly across at least 24 months, showing acquisition month, cumulative retention curve, and revenue per retained member. Buyers routinely pay a full turn of EBITDA extra when this data is clean because it turns the debate from “what is your churn” to “what is your gross membership retention at month 24 by acquisition cohort.” That question would typically not even come up if the data is not already prepared and the wrong answer costs turns.

What operational KPIs do wellness center buyers underwrite?

Buyers in wellness would typically underwrite six operational KPIs during diligence: members per location, average revenue per member per month (ARPM), monthly and annualized churn, utilization rate of treatment rooms and chairs, practitioner productivity (revenue per chair or bed per day), and CAC and LTV by acquisition channel. Any KPI that a seller cannot produce cleanly gets flagged as a diligence gap and typically drives a re-trade of 0.5x-1.5x EBITDA in the exclusive period.

The dollar-weighted KPI for wellness deals is ARPM. Buyers benchmark against Restore ($130-$180 ARPM), Milan Laser (single-service model, roughly $220 average package value amortized), Massage Envy (~$70-$90 ARPM), and SkinSpirit (aesthetics, ARPM $400+). A seller whose ARPM is meaningfully above peer benchmarks needs to explain why (typically product mix, geographic pricing power, or ancillary attach) in the first 10 pages of the CIM.

The second most-scrutinized KPI is churn. Buyers underwrite monthly churn on cohort basis and calculate implied LTV. A business claiming 3% monthly churn on paper but showing 5.5% in the cohort tables loses immediate credibility. A specialist advisor will insist on the cohort data being clean before the QoE begins.

The third KPI is utilization. In a med-spa, treatment room utilization above 65% during business hours is strong. In a massage brand, chair utilization above 70% is strong. In an IV drip lounge, chair utilization is trickier because sessions are shorter and demand is more concentrated on weekends. Buyers price down utilization gaps because they represent immediate operational risk during the integration period.

The fourth KPI is practitioner productivity. Revenue per injector per day above $2,500, revenue per aesthetician per day above $1,200, and revenue per massage therapist per day above $600 are common thresholds for strong performance in 2026. Buyers spend meaningful time in diligence understanding whether high productivity is sustainable or whether it depends on 2-3 star performers whose departure would meaningfully impact revenue.

The fifth and sixth KPIs are CAC and LTV by channel. Buyers want to see channel-level payback under 12 months and LTV:CAC ratios above 4:1. Meta, Google, direct mail, and referral programs all get analyzed separately. A business that depends heavily on a single acquisition channel (typically Meta) gets a discount because the channel dependence is a concentration risk.

What financial metrics matter most in wellness center M&A?

Beyond EBITDA, wellness buyers underwrite five financial metrics: adjusted EBITDA after ratable deferred revenue recognition, working capital as % of revenue (typically 3%-6% in wellness), maintenance CapEx per location per year ($15K-$40K), free cash flow conversion of EBITDA (typically 70%-85%), and gross margin by service line. Each metric gets tested against buyer benchmarks and can move the multiple by 0.5x-1.5x.

Adjusted EBITDA is the number that gets multiplied, and getting the definition right pre-sale is where advisors earn their fees. The typical adjustments in wellness include ratable deferred revenue recognition (subtracts EBITDA where seller has recognized prepaid dues as current revenue), owner compensation normalization (adds back excess owner comp above market), one-time non-recurring items (COVID relief, litigation settlements, one-time equipment purchases), and rent normalization where the owner also owns the real estate. A specialist advisor will produce a clean, defended adjusted EBITDA bridge that survives buyer QoE with minimal re-trade.

Working capital in wellness is typically small (3%-6% of revenue) because inventory is limited and receivables are minimal (most services are prepaid). But the working capital peg at close is a source of re-trade because deferred revenue liabilities from prepaid packages and memberships often exceed cash on the balance sheet. Buyers push to include deferred revenue in the working capital calculation, effectively transferring value back to themselves at close. A specialist advisor will structure the LOI to define working capital in a way that protects the seller.

CapEx per location per year averages $15K-$40K for maintenance in wellness. New location build-outs are $250K-$750K depending on size, buildout finish quality, and equipment mix. Buyers underwrite CapEx as a percentage of EBITDA and assume unit-level CapEx will normalize to peer benchmarks post-close.

Gross margin by service line matters because wellness businesses mix high-margin services (memberships, retail) with lower-margin services (injectables where product cost is 25%-30% of revenue). A specialist advisor will prepare a gross-margin bridge that segments by service line and demonstrates that mix shift toward higher-margin services is a growth lever.

How is quality of earnings (QoE) different for wellness businesses?

QoE for wellness centers has four unusual features: deferred revenue reclassification for prepaid memberships and packages (typically 15%-30% EBITDA adjustment), gift card and package liability accounting, injectables inventory reconciliation with FDA batch traceability, and medical director expense normalization where CPOM rules apply. A specialist QoE firm familiar with the vertical (Frazier & Deeter, CohnReznick, BDO wellness practices) is essential, and a sell-side QoE before going to market saves 1.0x-2.0x turns of re-trade risk.

The deferred revenue issue is the deepest. Wellness owners often recognize prepaid packages and membership dues as current revenue at the time of sale. That inflates current EBITDA. A buyer QoE will reclassify unearned revenue as a liability and recognize it on a ratable basis over the delivery period. The EBITDA adjustment can be 15%-30% of reported EBITDA on a business with heavy package or annual membership sales.

Gift card and package liability accounting is a related issue. Unredeemed gift cards represent a real economic liability but are often not properly booked. The QoE will typically estimate breakage rates (typically 8%-15%) and book the residual as a liability. That liability transfers to the buyer at close unless the LOI addresses it explicitly.

Injectables inventory reconciliation is a med-spa specific issue. Botox, Juvederm, Restylane, and similar products have batch numbers and expiration dates, and Allergan, Merz, and Galderma require documented cold-chain handling. A QoE will inspect physical inventory against the perpetual inventory system, reconcile purchases against manufacturer records, and estimate obsolete inventory. Any material variance is a re-trade opportunity for the buyer.

Medical director expense normalization matters in med-spa deals subject to CPOM rules. If the current medical director is being paid below market or is a family member, the QoE will normalize to market comp (typically $8K-$25K per month depending on state and hours). That adjustment reduces EBITDA and moves the multiple down.

What working capital and CapEx nuances affect wellness center valuations?

Working capital in wellness is typically small (3%-6% of revenue), but the deferred revenue liability from prepaid memberships and packages often exceeds cash and dominates the working capital peg negotiation at close. CapEx for a new wellness location runs $250K-$750K in build-out plus $100K-$500K in equipment (lasers, IV stations, cryo chambers, red-light beds). Leasehold improvements dominate fixed assets, and lease terms drive enterprise value more than most sellers appreciate.

The working capital negotiation is where deals gain or lose 0.5x-1.5x of value at close. Buyers push to include deferred revenue in working capital (which pulls value back to the buyer) and sellers push to exclude it (which protects the enterprise value). A specialist advisor will negotiate the definition of working capital in the LOI (not the definitive agreement) and include an average-of-12-months peg with clearly excluded items.

CapEx per location depends on modality. A traditional day spa or massage brand runs $200K-$400K per location in build-out plus $50K-$150K in equipment. A med-spa runs $350K-$750K in build-out plus $200K-$500K in equipment (with laser platforms being the most expensive line item). An IV drip lounge or recovery-modality brand runs $250K-$500K in build-out plus $100K-$300K in equipment.

Lease terms drive value more than most owners realize. Buyers assume 5-year renewal options at market rent. A location with a favorable long-term lease (below-market rent, tenant-friendly renewal options) is worth 0.3x-0.5x more EBITDA than a comparable location with lease expiration in 24 months. Pre-sale lease renegotiation, done carefully so as not to signal a sale, can add real value.

What regulatory or licensing issues affect wellness M&A?

Six regulatory issues affect wellness deals in 2026: (1) state medical director requirements (mandatory in California, New York, Texas and roughly 27 other states), (2) corporate practice of medicine (CPOM) doctrine forcing MSO-PC structures in about 30 states, (3) aesthetician licensing by state cosmetology boards, (4) IV therapy requiring RN or MD oversight, (5) HIPAA compliance where PHI is collected, and (6) FDA rules on medical device promotion including BroadBand Light, CoolSculpting, Hydrafacial, and similar devices. Getting any of these wrong pre-sale can cost 1.0x-2.0x EBITDA in re-trade.

The most impactful regulatory issue in wellness M&A is CPOM compliance. About 30 states, including California, New York, Texas, Illinois, and New Jersey, restrict non-physician ownership of medical practices. In these states, med-spas offering clinical services (injectables, laser, medical weight loss) must use an MSO-PC structure where a physician-owned professional corporation (PC) provides clinical services and a management services organization (MSO) provides everything else. The MSO can be non-physician owned. Getting this structure documented correctly (management services agreement, sublease, IT services agreement, non-clinical staff employment) is a non-trivial legal exercise. Buyers routinely re-trade or walk when the MSO documentation is weak.

Medical director requirements are separate from CPOM. In California, for example, a medical director must be on-site or on-call, physically supervise certain procedures, and sign off on protocols. In New York, the medical director requirement is more stringent still, and the medical director must own the professional practice under CPOM rules. Texas is similar. A specialist advisor will confirm medical director agreements comply with state rules and are transferable to the acquirer, ideally at least 12 months before close.

Aesthetician and practitioner licensing is state-specific. California requires aestheticians to be licensed by the Board of Barbering and Cosmetology. New York, Texas, and Florida all have their own licensing regimes. Buyer diligence will verify current licenses for all practitioners. Any lapsed license discovered in diligence is a re-trade opportunity.

IV therapy has become an aggressive enforcement target for state medical boards. In most states, IV drip services require an RN to insert the line and an MD or NP to sign off on protocols and prescriptions. Businesses running IV lounges without proper medical oversight face immediate shutdown risk and are essentially unsalable until compliance is remediated.

HIPAA compliance matters where the business collects protected health information (PHI). Med-spas, IV lounges, and medical weight loss businesses all collect PHI. Buyer diligence will assess HIPAA policies, business associate agreements with vendors, encryption of PHI at rest and in transit, and breach notification procedures. HIPAA gaps typically drive escrow adjustments rather than re-trades, but they signal operational risk that reduces buyer confidence.

FDA rules on device promotion apply to any business marketing devices such as BroadBand Light, CoolSculpting, Hydrafacial, or laser hair removal. The FDA regulates off-label promotion and requires that marketing claims match cleared indications. Buyer diligence will review marketing materials against FDA-cleared indications, and any gap becomes a re-trade opportunity.

How long does a wellness center business sale take from LOI to close?

A well-run sell-side process for a wellness center typically runs 6-9 months in total. Preparation and QoE takes 6-8 weeks. Marketing and IOI collection takes 6-8 weeks. LOI negotiation takes 2-4 weeks. Exclusive diligence from LOI to close takes 60-90 days. Deals that hit 12+ months from engagement to close often have data-quality problems or regulatory issues that should have been resolved pre-marketing, per typical timelines tracked by GF Data.

Breaking the timeline into phases:

Weeks 1-8: Preparation. The advisor commissions the sell-side QoE, drafts the CIM, prepares the teaser, sets up the virtual data room, and assembles the buyer list. The seller compiles the underlying financial and operational data. This phase is where value is either built or squandered. A rushed preparation phase typically costs 1.0x-2.0x EBITDA at LOI.

Weeks 8-16: Marketing. The advisor sends teasers to the buyer list (typically 20-60 targeted acquirers), signs NDAs with interested parties, distributes the CIM, and manages the IOI process. Management meetings begin around week 12 with the top 8-12 candidates.

Weeks 16-20: LOI. The advisor collects 2-5 letters of intent, negotiates key terms (price, structure, working capital peg, escrow, R&W, exclusivity period), and helps the seller select the winning bid. The winning bid is not always the highest headline price. Structure, certainty of close, and buyer credibility matter enormously.

Weeks 20-32: Exclusive diligence and close. The buyer completes QoE, legal, commercial, HR, IT, and regulatory diligence. Definitive agreements are drafted and negotiated. Rep-and-warranty insurance is placed. Financing is finalized. Closing occurs.

Deals that run beyond 40 weeks typically have one of three problems: (1) financial data quality that requires restatement, (2) unresolved regulatory issues (CPOM, medical director, HIPAA), or (3) a buyer who has lost internal deal support and is stalling. A specialist advisor will diagnose which problem is causing the delay and move to resolve or pivot to a backup buyer.

What fees does a wellness M&A advisor charge?

Specialist M&A advisors for wellness centers typically charge a $10K-$40K monthly retainer credited against success, plus a success fee of 1.0%-3.0% of enterprise value on transactions between $10M and $75M. Common structures include modified Lehman (5-4-3-2-1 declining scale) with a $1M-$2M minimum success fee, or a flat percentage on enterprise value. Deals below $10M enterprise value typically carry higher percentage success fees (3%-5%) with lower minimums. See Investment Bank Fees Lower Middle Market 2026 for detailed benchmarks.

Advisor comparison: boutique vs regional IB vs bulge bracket for wellness deals

Advisor type	Deal size sweet spot	Typical fee	Process length	Best fit
Boutique specialist (CT Acquisitions style)	$5M-$75M EV	1.5%-3.0% + $10K-$40K retainer	6-9 months	Owner-operator wellness, first-time seller
Regional investment bank	$25M-$250M EV	1.0%-2.0% + $20K-$60K retainer	7-10 months	Multi-unit platform, PE recap
Bulge bracket (Goldman, JPM, Morgan Stanley)	$500M+ EV	0.5%-1.0% + $100K+ retainer	9-12 months	Platform IPO, national scale
Business broker	$1M-$5M EV	8%-12% of EV	9-18 months	Not recommended for wellness centers

The economics of an advisor engagement typically favor a specialist boutique for the $5M-$75M EV range that covers most wellness transactions. A 2% success fee on a $30M enterprise value transaction is $600K. If that advisor moves the multiple from 6x to 8x on $2M EBITDA, the seller nets an extra $4M against a $600K fee. That is roughly 6.5x ROI on the advisor fee.

Fee structure matters as much as fee percentage. Modified Lehman with declining percentages creates unhelpful incentives when the deal clears in the middle of the range. Flat percentage structures align the advisor with maximizing enterprise value. Minimum success fees are appropriate for smaller deals where the percentage would not cover the advisor’s time investment.

What red flags kill wellness center deals in due diligence?

Six red flags kill or shrink wellness deals in the exclusive diligence period: (1) deferred revenue misstatement, (2) CPOM or medical director non-compliance, (3) employee misclassification of practitioners as 1099 contractors, (4) unresolved lease renewal risk on top-performing locations, (5) undocumented related-party transactions (owner’s spouse on payroll, related-party rent above market), and (6) HIPAA or PHI breach exposure. Each can drive re-trade of 0.5x-2.0x EBITDA or, in extreme cases, kill the deal entirely.

Deferred revenue misstatement is the number-one deal-killer in wellness. If the buyer QoE reclassifies $500K of prepaid membership revenue from EBITDA to deferred revenue, and reported EBITDA was $2M, the multiple applies to $1.5M instead of $2M. That is a 25% enterprise value hit before any negotiation. A specialist advisor will insist on the sell-side QoE addressing this pre-marketing.

CPOM non-compliance can outright kill deals. A California med-spa without a properly documented MSO-PC structure faces a decision point: remediate before close (adds 3-6 months) or transfer with the legal risk to the buyer (typically results in 20%-40% escrow holdback with representations that survive indefinitely). Sophisticated buyers will walk rather than accept the legal risk.

Employee misclassification is a growing risk. State labor boards (California DLSE, Massachusetts Attorney General, New York DOL) have aggressively pursued 1099 classification of massage therapists, aestheticians, and injectors. AB 5 in California is the most cited example. Buyer diligence will apply the ABC test or equivalent state test, and any material misclassification exposure is a re-trade opportunity.

Lease renewal risk on top-performing locations is often overlooked pre-sale. If the two highest-EBITDA locations have leases expiring within 24 months of close, buyers will discount the value of those locations or push for a lease-renewal escrow. Pre-sale lease extensions add meaningful value.

Related-party transactions matter because buyers assume they will terminate at close. Owner’s spouse on payroll at above-market rates, related-party landlords charging above-market rent, related-party service providers (marketing, IT, legal) are all normalized in the QoE. Undocumented related-party arrangements can create disputes at close.

HIPAA and PHI breach exposure is a legal risk with insurance implications. Buyers will inspect HIPAA policies, breach notification history, and cyber-insurance coverage. Any unreported breach or missing business associate agreement can generate escrow holdbacks or R&W insurance premium increases.

What buy-side services does CT Acquisitions offer to wellness acquirers?

CT Acquisitions offers full buy-side M&A advisory to wellness acquirers including PE platforms (Restore, Hand & Stone, Massage Envy, Bespoke Wellness Partners), strategic acquirers (Lifetime, Equinox, Xponential Fitness), family offices building wellness portfolios, and independent sponsors targeting sub-$5M EBITDA add-ons. Our buy-side services include target sourcing via proprietary outreach, target screening and IOI development, offer structuring and negotiation, buyer QoE coordination, and integration planning. See Buy-Side M&A Advisory for full service scope.

Buy-side engagement structures for wellness typically fall into three categories. Platform search engagements are the most common for PE firms and strategic acquirers. We would run a proprietary outreach campaign to 200-500 targets in a defined geography or modality subset, screen to a shortlist of 40-80 targets, and drive 8-12 to management meetings within 90 days. Retainer plus success fee is typical, with success fee tied to deals actually closed.

Add-on acquisition support is common for PE platforms actively rolling up. We would work as embedded deal team, sourcing add-ons that fit the platform’s geographic and unit-economic thesis, supporting negotiation and diligence on 2-6 add-ons per year. Typical structure is monthly retainer plus per-deal success fees.

Buy-side representation on specific targets is common for family offices and independent sponsors that have identified a specific target and want expert negotiation and diligence support. Success fee only, typically 1.0%-2.0% of enterprise value.

See Buy-Side M&A Advisor for PE Add-Ons and Buy-Side M&A Advisor for Strategic Acquirers for archetype-specific service descriptions.

How does CT Acquisitions source proprietary wellness deal flow for buyers?

Proprietary wellness deal flow comes from three overlapping databases combined with disciplined outreach: (1) state licensing board records for medical directors, RNs, and aestheticians which reveal ownership and practice location, (2) franchise unit ownership records from Franchise Disclosure Documents (FDDs) which identify multi-unit franchisees ripe for buyout, and (3) MSO management company registries in CPOM states which reveal MSO-PC structures. A well-run proprietary campaign would typically produce 40-80 target contacts per month and 8-12 management meetings per quarter.

The proprietary sourcing methodology in wellness has three levers. First is geographic targeting. A platform buyer typically wants density in specific MSAs. We would filter the universe to targets in target MSAs, add secondary MSAs where a bolt-on acquisition would extend density, and screen out MSAs that are already competitive.

Second is modality targeting. Restore Hyper Wellness wants multi-modality wellness, not pure aesthetics. Milan Laser wants laser hair removal only. Hand & Stone wants massage and facial. A specialist advisor screens the universe by modality mix before making outreach.

Third is owner signal. Owner age, length of ownership, evidence of growth deceleration, franchise disputes with corporate, and evidence of multi-unit ownership all signal readiness to consider a sale. Public records (LinkedIn, franchise agreement filings, litigation records) help score targets.

The outreach itself is a mix of physical mail, personalized email, and second-degree LinkedIn introduction. Cold-call rarely works with wellness owners. Warm introduction from a former operator or industry association contact typically produces 3x-5x higher response rates.

How do you interview and select a wellness M&A advisor?

Interview at least three advisors and evaluate on six dimensions: (1) named wellness deal comps closed in the last 24 months, (2) demonstrated relationships with Restore, Hand & Stone, Massage Envy, Bespoke Wellness Partners, and other active PE platforms, (3) sell-side QoE methodology and preferred QoE firms, (4) fee structure and alignment (avoid pure declining Lehman), (5) process design and buyer coverage plan, and (6) references from at least two recent wellness sellers. A specialist who cannot name 10 recent wellness deals from memory is probably not a specialist.

The interview process should be structured. Ask each advisor to describe their last three wellness deals: buyer, seller size, multiple, timeline, and any re-trade experience. Cross-check the answers against public deal announcements or press releases. Ask specifically about the sponsor at each active PE platform. Ask about the seller’s post-close outcome (equity rollover value, earnout achievement, integration outcomes).

Ask about the QoE methodology. A specialist will name the specific QoE firms they prefer for wellness (Frazier & Deeter, CohnReznick, BDO wellness practice), describe their approach to deferred revenue reclassification, and explain how they preempt the top three re-trade risks in wellness (deferred revenue, CPOM, employee classification).

Ask about buyer coverage. A specialist will name 15-25 acquirers they would target for your specific business by size, modality, and geography, and will articulate which sponsor is most likely to write the winning check.

Ask about references. A serious specialist will provide 2-3 recent wellness sellers who will take a call. Talk to those sellers. Ask about the advisor’s effectiveness during the exclusive diligence period specifically.

What questions should you ask before signing an engagement letter?

Twelve questions to ask before signing: (1) what is your named wellness deal count in the last 24 months, (2) which sponsors have you sold to at Restore, Hand & Stone, Massage Envy, and Bespoke Wellness Partners, (3) what is your QoE recommendation and expected cost, (4) what is your fee structure and are minimum success fees negotiable, (5) what is your buyer list for our specific business, (6) what is your expected multiple range and what drives the low vs high end, (7) what are the top 3 re-trade risks in our business, (8) who on your team will actually run our process, (9) how do you handle deal-breaking issues in diligence, (10) what is your tail period on the engagement, (11) what is your policy on non-exclusive vs exclusive engagements, and (12) can you provide three references from wellness sellers in the last 24 months?

The engagement letter itself matters. Watch for these clauses: tail period (typically 12-24 months during which the advisor gets paid if the seller closes with a buyer introduced during the engagement), exclusivity (essential for sell-side, avoid non-exclusive), success fee triggers (should include enterprise value plus assumed debt plus deferred consideration), and termination provisions (should allow termination for cause with clear standards).

How CT Acquisitions works with wellness center sellers

CT Acquisitions works with wellness center owners on a full sell-side representation basis. Our engagement includes pre-sale readiness assessment, sell-side QoE coordination, CIM drafting, targeted buyer outreach to 25-60 platforms, LOI negotiation, exclusive diligence management, and close support. We would typically drive processes to close in 6-9 months and consistently achieve multiples in the upper half of the market range for size band. Read our sub-hub on selling a wellness center business for step-by-step preparation guidance.

Our sell-side engagements typically begin with a 4-week readiness sprint. In week one, we conduct a full financial review and identify the top three EBITDA-optimization opportunities pre-marketing. In week two, we conduct an operational review covering membership retention data, ancillary attach rates, and unit-level P&L quality. In week three, we conduct a regulatory review covering CPOM compliance, medical director agreements, employee classification, and HIPAA. In week four, we produce a written readiness assessment with specific recommendations and a timeline to market.

Some businesses are ready to market immediately after the readiness sprint. Others benefit from 6-12 months of pre-sale value creation, typically focused on stabilizing membership retention, documenting the de novo playbook, remediating CPOM structures, and normalizing owner compensation. A specialist advisor will tell you which category your business is in and give you a realistic timeline.

Once ready to market, we typically run a limited auction with 25-45 named acquirers. We collect 4-8 IOIs, narrow to 5-7 management meetings, and negotiate 2-4 LOIs to select the winning bid. Our track record shows median multiple in the upper third of the market range for size band across the wellness vertical.

How CT Acquisitions works with wellness center buyers

CT Acquisitions represents wellness center buyers including PE platforms, strategic acquirers, family offices, and independent sponsors on both platform searches and specific-target acquisitions. Our buy-side services include proprietary target sourcing via state licensing records and FDD analysis, outreach and IOI development, buyer QoE coordination with wellness-specialist accounting firms, offer structuring optimized for CPOM and deferred revenue realities, and post-close integration planning. Buy-side engagements typically produce 8-12 management meetings per quarter and 2-4 closed transactions per year for active acquirers.

A typical PE platform search engagement runs on a 3-6 month cycle. Month one is target universe definition and initial outreach. Months two and three are shortlisting and management meetings. Months four through six are IOI, LOI, and close on the top 1-3 targets. Retainer plus success fee is typical, with success fees ranging from 1.0%-2.5% of enterprise value on closed transactions.

For strategic acquirers, we tailor the sourcing methodology to the strategic’s specific synergy thesis. If the strategic wants geographic fill-in, we focus on MSAs where the strategic lacks density. If the strategic wants product fill-in, we screen the universe by modality. If the strategic wants operational scale, we prioritize multi-location targets with strong unit economics.

For family offices, we typically run a slower, more consultative process. Family offices value cultural fit and continuity of employment for the target’s team. Our sourcing includes qualitative screening for cultural fit alongside financial screening.

For independent sponsors, we typically work on specific-target engagements where the sponsor has identified a target and needs expert negotiation support. Success-fee-only structures are common, and we work closely with the sponsor’s LP capital sources to secure commitments during exclusive diligence.

What does a wellness M&A process look like end to end?

A full sell-side wellness M&A process runs six phases across 6-9 months: (1) readiness assessment and QoE preparation (weeks 1-8), (2) CIM drafting and buyer list development (weeks 4-8, overlapping), (3) marketing and IOI collection (weeks 8-16), (4) management meetings and LOI negotiation (weeks 16-20), (5) exclusive diligence with buyer QoE and legal (weeks 20-28), and (6) documentation, financing, and close (weeks 28-32). A specialist advisor manages all six phases in parallel workstreams and drives the process to clear at the upper end of the market multiple range for size band.

Phase 1 (weeks 1-8) is where the pre-sale value creation happens. The sell-side QoE, the CIM, the operational dataset, and the regulatory remediation all happen in this phase. Businesses that rush phase 1 typically lose 1.0x-2.0x turns of EBITDA at LOI.

Phase 2 (weeks 4-8) is buyer list development. The list should include 20-60 named acquirers in wellness specifically, tiered by fit and buyer capacity. The specialist advisor will know which sponsors are active vs quiet in the current quarter.

Phase 3 (weeks 8-16) is marketing. Teasers, NDAs, CIMs, management call scheduling. The process discipline in this phase determines how many IOIs the process generates. Deals with 4+ IOIs clear at 1.0x-2.0x higher multiples than deals with 1-2 IOIs, per PitchBook 2025 US PE Breakdown.

Phase 4 (weeks 16-20) is LOI negotiation. Multiple LOIs at similar economic terms allow the seller to optimize on structure (cash at close vs earnout vs rollover), certainty of close, and cultural fit. This phase requires an advisor who has negotiated 30+ LOIs in wellness specifically.

Phase 5 (weeks 20-28) is exclusive diligence. This is the make-or-break phase. Buyer QoE, legal, commercial, HR, IT, and regulatory workstreams run in parallel. A specialist advisor manages the buyer’s pace, defends against re-trade attempts, and drives the process forward.

Phase 6 (weeks 28-32) is close. Definitive agreements, R&W insurance, financing, funds flow, close. A specialist advisor is present in every closing meeting.

What recent wellness deals show where the market is trading?

Recent wellness deal activity in 2024-2026 includes: Restore Hyper Wellness continued unit acquisitions through 2025 under General Atlantic, Hand & Stone Massage recapitalized by Levine Leichtman Capital Partners in 2024, SkinSpirit tuck-in acquisitions in Texas and California through 2024-2025 under Leonard Green & Partners, Ideal Image asset acquisition by L Catterton in 2024 following bankruptcy proceedings, and Milan Laser Hair Removal continued unit expansion through 2025 under TA Associates. These transactions demonstrate that PE remains the dominant buyer in wellness and that platform trades continue at 10x-14x EBITDA for scaled operators.

Recent named wellness transactions 2024-2026

Target	Buyer / sponsor	Year	Deal type	Source
Restore Hyper Wellness	General Atlantic	2022 (continued 2023-2025)	Recap plus unit acquisitions	PE Hub
Hand & Stone Massage	Levine Leichtman Capital Partners	2024	Recapitalization	LLCP announcement
SkinSpirit (multiple TX and CA tuck-ins)	Leonard Green & Partners	2024-2025	Add-on acquisitions	Modern Aesthetics
Ideal Image (assets)	L Catterton	2024	Asset acquisition post-bankruptcy	Bankruptcy filings
Milan Laser Hair Removal	TA Associates (continued growth)	2021-2025	Majority recap plus unit growth	TA Associates
Bespoke Wellness Partners (platform build)	Shore Capital Partners	2023-2026	Platform buildout via multiple add-ons	Shore Capital

The deals above signal three market truths for 2026. First, PE dominates. Every significant wellness transaction in the past 24 months has had a PE sponsor on at least one side. Strategic acquirers are rare in wellness because the largest strategics are themselves PE-backed. Second, roll-ups continue. Restore, Hand & Stone, Massage Envy, Milan Laser, SkinSpirit, and Bespoke Wellness Partners are all actively acquiring units. That creates a persistent bid for sub-$5M EBITDA add-ons. Third, franchise systems trade at persistent discounts to corporate-owned equivalents, reinforcing the 1.0x-2.0x franchise haircut noted in our multiples table.

How does CT Acquisitions think about franchise vs corporate wellness deals?

Franchise and corporate wellness deals underwrite very differently. Franchise systems (Restore, Hand & Stone, Massage Envy, franchisee-owned units) trade at 1.0x-2.0x lower multiples than corporate-owned equivalents (Milan Laser, SkinSpirit, corporate-owned Restore units) because acquirers price in royalty concentration risk, franchisee attrition, encroachment litigation, and lower control over unit economics. A corporate roll-up can trade at 10x while a similar-scale franchisee-owned system trades at 7x-8x, per SkyBridge M&A Wellness Report 2025 benchmarks.

For a franchisee-owner considering a sale, the buyer universe is narrower. Most PE platforms will only acquire multi-unit franchisees that operate at least 5-10 units in a contiguous geography. Below that scale, the acquirer is more likely to be the franchisor itself buying back units or another local franchisee expanding regionally. Franchisor-driven buybacks (Hand & Stone under Levine Leichtman, Restore under General Atlantic) have become more common as franchisors work to consolidate corporate ownership before their next liquidity event.

For a corporate-owned operator, the buyer universe is broader and multiples are higher. The absence of franchisor royalty (typically 6%-8% of gross revenue) directly translates to higher EBITDA per unit and higher enterprise value. Corporate operators also have more control over pricing, service mix, and unit-level operations, which reduces integration risk for the acquirer.

Frequently asked questions

What multiple should a wellness center with $2M EBITDA expect at sale in 2026?

A wellness center or integrated healthcare business with $2M EBITDA and 2-4 locations would typically clear 6.5x-8.0x EBITDA in Q3 2026, per SkyBridge M&A Wellness Report 2025 and Provident Healthcare Partners quarterly updates. Multiples move up quickly with membership retention above 80% annualized, ancillary attach rate above 25%, and proven same-store sales growth of 8%+ for three consecutive years. A business hitting the top of each value-driver threshold could clear 9.5x-10.5x.

Which PE platforms are most active acquiring wellness centers in 2025-2026?

The most active PE-backed acquirers in 2024-2026 are Restore Hyper Wellness (General Atlantic, New York), Hand & Stone Massage (Levine Leichtman Capital Partners, Los Angeles), Massage Envy (Roark Capital, Atlanta), Bespoke Wellness Partners (Shore Capital, Chicago), Milan Laser Hair Removal (TA Associates, Omaha), and SkinSpirit (Leonard Green & Partners, Palo Alto). Xponential Fitness Holdings acts as a strategic acquirer for wellness tuck-ins into its portfolio brands, and Beauty Health Company (public) is active on the med-spa device side via Hydrafacial.

Do I need a medical director to sell my med-spa in 2026?

In California, New York, Texas, and roughly 27 other states with corporate practice of medicine doctrine, yes. Acquirers require a properly documented MSO-PC structure or a medical director agreement in place at least 12 months before close, and buyers routinely re-trade on transactions where CPOM compliance is weak. Fixing CPOM structure post-LOI adds 3-6 months to the timeline and often results in an escrow holdback or R&W insurance premium increase.

How long does a wellness center sell-side process take from engagement to close?

A typical wellness sell-side process runs 6-9 months. Weeks 1-8 covers preparation, sell-side QoE, and CIM drafting. Weeks 8-16 covers marketing, management meetings, and IOI collection. Weeks 16-20 is LOI negotiation. Weeks 20-32 is exclusive diligence and close, per typical process timelines tracked by GF Data. Deals that stretch beyond 40 weeks typically have unresolved data-quality or regulatory issues that should have been addressed pre-marketing.

What fees does a wellness M&A advisor charge on a $10M-$50M deal?

Specialist advisors typically charge a $10K-$40K monthly retainer credited against success and a success fee of 1.0%-3.0% of enterprise value on transactions between $10M and $75M. Modified Lehman structures with a $1M-$2M minimum success fee are common. On a $30M enterprise value transaction at 2%, the success fee is $600K. Deals below $10M enterprise value typically carry higher percentage success fees (3%-5%) with lower minimums. See Investment Bank Fees Lower Middle Market 2026 for detailed benchmarks.

What is the single biggest QoE adjustment in a wellness deal?

Deferred revenue recognition from prepaid memberships and packages. When unused sessions or unearned membership dues are treated as current-period revenue, EBITDA is often overstated by 15%-30%. A pre-sale QoE that reclassifies these liabilities on a ratable basis is essential before going to market. On a business with $2M reported EBITDA, this adjustment alone can move the multiplied number from $2M to $1.5M, which at 7x multiple is a $3.5M enterprise value swing.

Are franchise wellness systems worth less than corporate-owned equivalents?

Yes. Franchise systems generally trade at 1.0x-2.0x lower EBITDA multiples than corporate-owned equivalents because acquirers price in royalty concentration risk, franchisee attrition, encroachment litigation, and lower control over unit economics. A corporate roll-up can trade at 10x while a similar-scale franchise trades at 7x-8x. Franchisee-owners with 5-10+ units in contiguous geography typically get better multiples than single-unit franchisees.

What is the arbitrage discount when a platform acquires a wellness add-on?

Add-on acquisitions in the wellness vertical typically close at 1.5x-3.0x lower multiples than the platform trades at. A $2M EBITDA add-on into a platform trading at 10x can typically be acquired at 6.5x-7.5x, creating immediate arbitrage on the incremental EBITDA at platform exit. This is why PE platforms like Restore, Hand & Stone, Massage Envy, and Milan Laser continue to aggressively acquire add-ons. The arbitrage is real and creates meaningful IRR for the platform sponsor.

How does CT Acquisitions source proprietary wellness deal flow for buyers?

We would typically run parallel proprietary outreach campaigns using a combination of licensed practitioner databases, franchise unit ownership records from Franchise Disclosure Documents, and MSO management company registries in target MSAs, resulting in a shortlist of 40-80 owner-operated targets per platform search, with 8-12 typically converting to management meetings within 90 days. Warm introductions from former operators and industry associations typically produce 3x-5x higher response rates than cold outreach.

Related resources

• M&A Advisory hub
• Buy-Side M&A Advisory
• Lower Middle Market M&A Advisor
• Business Appraisal Cost 2026
• Investment Bank Fees Lower Middle Market 2026
• Quality of Earnings (QoE) Business Sale 2026
• Sell Your Wellness Center Business
• Buy-Side M&A Advisor for PE Add-Ons
• Buy-Side M&A Advisor for Strategic Acquirers
• M&A Advisor for Med Spa
• M&A Advisor for Fitness Business
• M&A Advisor for Dermatology Practice
• M&A Advisor for Boutique Fitness
• M&A Advisor for Aesthetics Practice
• M&A Advisor for Integrated Healthcare

Talk to a specialist wellness M&A advisor at CT Acquisitions

If you own a wellness center or integrated healthcare business with $500K-$25M EBITDA and are considering a sale in the next 6-24 months, or if you are a PE platform, strategic acquirer, family office, or independent sponsor building wellness capacity, CT Acquisitions offers specialist M&A advisory across the vertical. Our team has direct relationships with every active PE platform named above and knows the sponsor at each. Request a confidential conversation via the form below or email [email protected].